Effect of probiotics on the development of dimethylhydrazine-induced preneoplastic lesions in the mice colon

Acta Cir Bras. 2013 May;28(5):367-72. doi: 10.1590/s0102-86502013000500008.

Abstract

Purpose: To determine the effect of probiotics on the development of chemically induced (1, 2-dimethylhydrazine) colonic preneoplastic lesions, in mice.

Methods: The animals were divided into five groups. The control group was injected with carcinogen alone and the other groups also received probiotics (1- Lactobacillus delbrueckii UFV-H2b20; 2- Bifidobacterium animalis var. lactis Bb12; 3- L. delbrueckii UFV-H2b20 plus B. animalis var. lactis Bb12; and 4- Saccharomyces boulardii) administered orally in drinking water throughout fourteen weeks.

Results: Consumption of lactobacilli and bifidobacteria alone resulted in a significant reduction of the total number of aberrant crypt foci (55.7% and 45.1%, respectively). Significant reduction in the number of these small foci (<3 aberrant crypts) was only observed in the group treated with lactobacilli (52.2%) in comparison to control group. The number of larger foci (>3 aberrant crypts) crypts had no significant reduction.

Conclusion: L. delbrueckii UFV-H2b20 and B. animalis var. lactis Bb12 administered alone protect colonic preneoplastic lesions in mice, while the combined treatment of these bacteria and the administration of S.boulardii were not effective in reducing such colonic lesions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aberrant Crypt Foci / chemically induced
  • Aberrant Crypt Foci / pathology
  • Aberrant Crypt Foci / prevention & control*
  • Animals
  • Bifidobacterium / physiology
  • Carcinogens
  • Colonic Neoplasms / chemically induced
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / prevention & control*
  • Combined Modality Therapy
  • Dimethylhydrazines
  • Lactobacillus delbrueckii / physiology
  • Male
  • Mice
  • Precancerous Conditions / chemically induced
  • Precancerous Conditions / pathology
  • Precancerous Conditions / prevention & control*
  • Probiotics / pharmacology*
  • Reproducibility of Results
  • Saccharomyces / physiology
  • Time Factors

Substances

  • Carcinogens
  • Dimethylhydrazines